e-learning
resources
Virtual 2020
Pre-Congress Content
Tuberculosis and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comorbidome in multidrug-resistant tuberculosis patients
D. Ivanova (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), N. Nikolenko (Moscow, Russian Federation), S. Kosenkov (Moscow, Russian Federation)
Source:
Virtual Congress 2020 – Tuberculosis and comorbidities
Session:
Tuberculosis and comorbidities
Session type:
E-poster session
Number:
479
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Ivanova (Moscow, Russian Federation), S. Borisov (Moscow, Russian Federation), N. Nikolenko (Moscow, Russian Federation), S. Kosenkov (Moscow, Russian Federation). Comorbidome in multidrug-resistant tuberculosis patients. 479
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Diagnosis of COPD in patients with multidrug-resistant tuberculosis
Source: International Congress 2018 – COPD around the world
Year: 2018
Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005
Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003
Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012
Extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB): a retrospective comparative study
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008
Treatment of drug-susceptible and drug-resistant tuberculosis
Source: Eur Respir Monogr 2018; 82: 152-178
Year: 2018
Management and treatment of multidrug-resistant tuberculosis
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019
Treatment options for patients with multidrug-resistant or extensively drug-resistant tuberculosis
Source: Annual Congress 2009 - Priorities in tuberculosis research
Year: 2009
Multidrug-resistant tuberculosis
Source: Annual Congress 2008 - The thoracic surgeon facing infection
Year: 2008
Multidrug-resistant tuberculosis (MDR-TB)
Source: Breathe 2010; 6: 283
Year: 2010
Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis
Source: Eur Respir J, 49 (5) 1700742; 10.1183/13993003.00742-2017
Year: 2017
Treatment‘s side effects in MDR tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 454s
Year: 2005
Susceptibility of
Mycobacterium tuberculosis
strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001
Prevalence of MDR and XDR tuberculosis among patients with failure of re-treatment course
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Recurrence after successful treatment among patients with multidrug-resistant tuberculosis
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Linezolid in multidrug-resistant tuberculosis treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 485s
Year: 2004
The radiological spectrum of pulmonary multidrug-resistant tuberculosis in HIV-negative patients
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005
The radiological spectrum of pulmonary multidrug-resistant tuberculosis in HIV-negative patients
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008
The radiological spectrum of pulmonary multidrug-resistant tuberculosis in HIV-negative patients
Source: Eur Respir J 2006; 28: Suppl. 50, 13s
Year: 2006
Extensively drug-resistant (XDR) pulmonary tuberculosis in HIV negative cases
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept